Sponsor
Ningbo Medical Center Lihuili Hospital
Clinical research sponsor
Clinical trials
17 shownThe Efficacy and Safety of Drug Loaded Microsphere Bronchial Artery Chemoembolization (DEB-BACE) Combined With Anlotinib and Adebelimumab in the Third Line Treatment of Advanced NSCLC: a Prospective, Single Arm, Single Center, Exploratory Clinical StudyNCT06188650 · lead sponsor · 2023-12-09
UNKNOWNEfficacy of Deep-coil Based Repetitive Transcranial Magnetic Stimulation in the Treatment of Parkinson's Disease With Freezing of Gait and Its Neural Regulation Mechanism Study of Resting-state Cerebral Blood FlowNCT06888778 · lead sponsor · 2023-02-01
COMPLETEDA Prospective Multicenter Study of the TuFEst-LN Model for Axillary Lymph Node Status Assessment in Breast CancerNCT07304934 · collaborator · 2025-08-01
RECRUITINGComparison of Sequential to Initial Combination Therapy in PAHNCT06968962 · collaborator · 2025-05-14
RECRUITINGEfficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label TrialNCT06863532 · collaborator · 2025-03-30
RECRUITINGRibociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast CancerNCT06587789 · collaborator · 2024-01-01
RECRUITINGPARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT05759546 · collaborator · 2023-02-01
RECRUITINGSNF Platform Study of HR+/ HER2-advanced Breast CancerNCT05594095 · collaborator · 2022-12-30
RECRUITINGRegistry for Longitudinal Mortality and Therapy in Patients With Heart FailureNCT04062500 · collaborator · 2018-01-01
RECRUITINGThe Chinese Familial Alzheimer's NetworkNCT03657732 · collaborator · 2005-01-10
RECRUITINGChina Cognition and Aging StudyNCT03653156 · collaborator · 2000-01-01
RECRUITINGLidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis RiskNCT07347977 · collaborator · 2026-01-01
NOT_YET_RECRUITINGA Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney DiseaseNCT07130955 · collaborator · 2025-08-08
ENROLLING_BY_INVITATIONPARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerNCT06612814 · collaborator · 2024-09-01
ACTIVE_NOT_RECRUITINGApatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast CancerNCT05759572 · collaborator · 2023-03-01
ACTIVE_NOT_RECRUITINGImmune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02NCT05205200 · collaborator · 2022-06-06
UNKNOWNObservational Study of ASCVD Risks of Type 2 Diabetes in East ChinaNCT04866667 · collaborator · 2021-05-01
COMPLETEDSponsor roles
collaborator15
lead sponsor2
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.